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Preface
This is the report of the eleventh of a series
of workshops organised by the European
Centre for the Validation of Alternative
Methods (ECVAM), which was established in
1991 by the European Commission.
ECVAM's main goal, as defined in 1993 by
its Scientific Advisory Committee, is to promote the scientific and regulatory acceptance
of alternative methods which are of impor-

tance to the biosciences and which reduce,
refine or replace the use of laboratory animals. One of the first priorities set by
EevAM was the implementation of procedures which would enable it to become wellinformed about the state-of-the-art of
non-animal test development and validation.
and the potential for the possible incorporation of replacement alternative tests into
regulatory procedures. It was decided that
this would be best achieved by the organisa-
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tion of ECVAM workshops on specific topics,
at which small groups of invited experts
would review the current status of various
types of in vitro tests and their potential
uses, and make recommendations about the
best ways forward (1).
The workshop on The Three Rs - The
Way Forward, held in Sheringham, Norfolk,
UK, on 30 May to 3 June 1995, under the cochairmanship of Michael Balls (ECVAMI and
Alan M. Goldberg (Johns Hopkins Center for
Alternatives to Animal Testing [CAAT],
Baltimore, MD, USAI, had a wider aim. The
principal objectives of this workshop were to
discuss the current status of the Three Rs,
and to make recommendations aimed at
achieving greater acceptance of the concept
of humane experimental technique and, in
the interests of both scientific excellence and
the highest standards of animal welfare, the
more active implementation of reduction
alternatives, refinement alternatives and
replacement alternatives.
The invited participants were individuals
actively and professionally committed to the
Three Rs, and we were privileged to have
William Russell and Rex Burch, who developed the Three Rs approach in the 1950s, as
participants in the workshop.
The opening ceremony was held in
Sheringham Town Hall, where Rex Burch
has practised as a microbiologist since the
early 1970s. Since this was the first time that
Russell and Burch had attended a scientific
conference together for nearly forty years,
the proceedingfi were recorded on videotape
(the VHS tape can be borrowed from
ECVAM and a JVC version is available from
CAATI. The rest of the workshop was held at
the Links Country Park Hotel, West Runton.

The origins of the Three Rs concept

project was managed by a committee under
the chairmanship of Sir Peter Medawar,
with William Lane-Petter, Secretary of the
Research Defence Society, among its members. It was international from its outset,
since Christine Stevens, of the Animal
Welfare Institute (AWl) in the USA, provided financial support and made frequent
visits to UF AW while the study was being
conducted.
W.M.S. Russell and R.L. Burch were
appointed to carry out the work. This led to
their book, The Principles of Humane
Experimental Techniq'le (2), which provided
a wealth of information and many remarkable ideas and insights, most of them as relevant today as they were more than 35 years
ago. The book has recently been reprinted
(31, and copies can be obtained from UFAW.'
It was in this book that Russell and Burch
presented the concept of the Three Rs. They
defined replacement as "any scientific
method employing non-sentient material
which may in the history of animal experimentation replace methods which use conscious living vertebrates", reduction as a
means of lowering "the number of animals
used to obtain information of a given amount
and precision", and refinement as any development leading to a "decrease in the incidence or severity of inhumane procedures
applied to those animals which have to be
used".
Nobody can recall precisely when the
Three Rs concept arose (4), but it was sometime between 1955 and 1957. UFAW held a
symposium on Humane Technique in the
LaboratolY (51 in 1957, and it was then that
the concept of the Three Rs was first discussed in public. More about the origins of
the Three Rs concept can be found in a talk
given by Charles Hume in Washington in
October 1959 (61, when he said of The
Principles of Humane Experimental
Technique:

What are now known as the Three Rs of
Russell and Burch, replacement, reduction
and refinement, have their origins in a proposal made in 1954 by Charles Hume,
founder of the Universities Federation for
Animal Welfare tUFAWI, that UFAW should
undertake a scientific study of humane technique in laboratory animal experiments. The

"This deserves to become a classic for all
time, and we have great hopes that it will
inaugurate a new field of systematic study.
We hope that others will follow up the lead it
has given, and that a generalised study of
humane technique, as a systematic compo·
nent of the methodology of research, will
come to be considered essential to the train-

Introduction
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ing of a biologist."
What is perhaps the central message (the
"humanity criterion") of The Principles of
Humane Experimental Techiqlle (2) is
spelled out on page 157 of the book:
"If we are to use a criterion for choosing
experiments to perform, the criterion of
humanity is the best we could possibly
invent."
"The greatest scientific experiments have
always been the most humane and the most
aesthetically attractive, conveying that sense
of beauty and elegance which is the essence
of science at its most successful."
The evolution of the Three Rs concept

Despite its originality and scholarship, and
the involvement of many distinguished sci·
entists in the discussions leading up to its
publication, Russell and Burch's book had
little obvious impact on thinking or practice
in the early years after its publication. In
fact, its authors did not meet each other
again for about 30 years, when they were
"rediscovered" by a new generation of
reformers.
However, in 1969, one particularly signifi·
cant development did take place - the foundation by Dorothy Hegarty of the Fund for
the Replacement of Animals in Medical
Experiments (FRAME), specifically to
advance Russell and Burch's vision that
humanitarian and scientific benefits would
result from the systematic and rational
application of the Three Rs approach.
FRAME saw reduction and refinement as'
achievable in the short term, but decided to
focus its own activities primarily on replacement as the ultimate, long-term goal (7).
FRAME was to succeed in establishing itself
in the middle ground between the antivivisectionists and the defenders of animal·
based research, with a positive message,
based not on confrontation, but on support
of the Three Rs concept.
In the 1970s, there were a number of other
significant events. For example, there was a
substantial increase in laboratory animal use
in the early part of the decade, which led to
great public concern in Great Britain, and an
Animal Welfare Year campaign, involving
many animal welfare organisations, was
organised to mark the centenary of the
Cruelty to Animals Act 1876 (8), the law
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under which experiments on animals were
allowed and regulated. This led in turn to the
formation of the Committee for the ,Reform
of Animal Experimentation (CRAE), which
had as its principal goal the reform of the
1876 Act (9). The concept of alternatives was
also taking hold in the USA. as a result oflhe
efforts of the AWl (who distributed Russell
and Burch's book), United Action for
Animals, and the Humane Society of the
United States.
Meanwhile, David Smyth, a distinguished
physiologist, was conducting a survey on the
Three Rs for the Research Defence Society,
which led to another important landmark,
the publication of his book on Alternatives to
Animal Experiments (10). Smyth provided a
Three Rs definition of alternatives, which
has since been widely accepted:
"All procedures which can completely
replace the need for animal experiments,
reduce the numbers of animals required, or
diminish the amount of pain or distress suffered by animals in meeting the essential
needs of man and other animals."
A number of particularly important
changes began to take place at the beginning
of the 1980s. In the USA, animal activist
Henry Spira launched a campaign to abolish
the Draize eye irritancy test, with the worldwide support of a coalition of 400 animal
organisations. In Europe, discussions began
which were later to lead to the Council of
Europe Convention for the Protection of
Vertebl:afe Animals Used for Experimental
and Other Scientific Plllposes (111 and
COllllcil Directive 8616091EEC of 24
November 1986 on the Approximation of
Laws, Regulations and Administrative
Provisions of the Member States Regarding
the Protection of Animals Used for
Experimental and Other ScientiJ;c Purposes
1121.
Meanwhile, the British Home Secretary,
Merlyn Rees, said that he would consider listening to proposals for the reform of the
1876 Act, but only if animal welfare organi.
sations would agree on a policy among themselves. An alliance was therefore formed
between CRAE, FRAME and the British
Veterinary Association (BVA; 9). A set of
BVNCRAE/FRAME proposals were submitted in 1983 113), which greatly influenced
British Government thinking, as revealed in
two White Papers (14, 151. In what was a
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very dramatic development at the time, the
1985 White Paper contained a commitment
to the Three Rs concept, in these words:

7.4. All experiments shall be designed to
avoid distress and unnecessary pain and suffering to the experimental animals.

"Animal experiments that are unnecessary,
use unnecessarily large numbers of animals,
or are unnecessarily painful, are indefensible."

Similar words are used in the Council of
Europe Convention (11),
In Germany, when the national legislation
on animal protection was changed in 1987 to
meet the requirements of Directive
86/609/EEC, a clause was inserted which
requires the Federal Government to present
a report (the Tierschzttzbericht) to the
Bundestag every two years, to document the
progress made with respect to the implementation of animal protection measures. This
puts pressure on the relevant government
institutions to take the necessary steps to
implement current legislative requirements
for animal protection. According to the
German animal protection act (the
Tierschutzgesetz), nobody is allowed to cause
pain, suffering or harm to an animal without
good reason. The legislation closely resembles Direclive 86/609/EEC, with an additional provision which prohibits animal
experimentation for developing tobacco
products, washing detergents and decorative
cosmetics.
In The Netherlands, the Act on Animal
Experimentation was adopted in 1977. Items
included in this Act which are of importance
with regard to the implementation of the
Three Rs are:

Members of the BVNCRAE/FRAME
alliance were invited to act as advisers to the
British Government during the preparation
and passage through Parliament of the
Animals (Scientific Procedures) Act 1986
061, which was supported by both the
Conservative and Labour parties and
replaced the 1876 Act. The 1986 Act set up a
project and personal licensing system, as well
as an independent Animal Procedures
Committee (APC), which can give advice to
the Government, whether or not it is
wanted. The Act contains two particularly
important clauses (161:
5141. In determining whether and on what

terms to grant a project licence the Secretary
of State shall weigh the likely adverse effects
on the animals concerned against the benefit
likely to accrue as a result of the programme
of work to be specified in the licence.
515 J. The Secretary of State shall not grant a
project licence unless he is satisfied that the
applicant has given adequate consideration
to the feasibility of achieving the purpose of
the programme to be specified in the licence
by means not involving the use of protected
animals.

Directive 86/609/EEC 1121 spelled out its
Three Rs basis in Article 7, as follows:
7.2. An experiment shall not be performed if
another scientifically satisfactory method of
obtaining the result sought, not entailing the
use of an animal, is reasonably and practica~
blyavailable.
7.3. When an experiment has to be performed, the choice of species shall be carefully considered and, where necessary,
explained to the authority. In a choice
between experiments, those which use the
minimum number of animals, involve animals with the lowest degree of neurophysiological sensitivity, cause the least pain,
suffering, distress or lasting harm and which
are most likely to provide satisfactory results
shall be selected.

a) Mandatory registration of animal use.
bl Prohibition of the use of an animal for a
purpose that could be achieved equally by
using in vitro methods or other non-ani~
mal procedures.
c) The requirement that persons involved in
animal experimentation are shown to be
competent. Education and training in the
field of laboratory animal science, includ~
ing ethics and alternatives, is mandatory
for scientists and animal technicians.
d) The requirement that institutions where
animal experiments are conducted must
be licensed.
e) The requirement that a certificated animal welfare officer be appointed in association with the licence for the institute.
D Mandatory use of anaesthetics and analgesics when appreciable pain is anticipated. Their use may only be omitted
when this would jeopardise the purpose
of the experiment.

ECVAM Workshop 11: Three Rs

At present, the 1977 Act is being revised; the
amended Act will include provisions relating
to Animal Experimentation Committees
(AECs; see section on Scientific and Ethical
Justification).
Following the adoption of the Act on
Animal Experimentation, several initiatives
were undertaken. A Department of
Laboratory Animal Science was established
at Utrecht University in 1983; in this
Department, research and education programmes have been developed which are
specifically directed toward further implementation of the Three Rs, and courses on
laboratory animal science are routinely held
for scientists. In 1987, the Dutch
Alternatives to Animal Experiments
Platform was established, through which
government, industry and animal welfare
organisations cooperate in order to stimulate
the development and use of alternative
methods. The main task of the Platform is to
advise the Government on the funding of
research projects concerned with the development of alternatives. The Netherlands
Centre Alternatives to Animal Use (NCA)
was established in Utrecht in 1994, as a
national information centre on alternatives.
The main objective of the NCA is to stimulate the development, validation, acceptance
and use of alternative methods; that is, the
NCA supports the Platform in seeking to
realise its goal.
In the USA, the Johns Hopkins Center for
Alternatives to Animal Testing (CAAT) was
founded in 1981, with the support of a grant
from the Cosmetic, Toiletry and Fragrance
Association, to address the major issues facing the development of alternatives (17).
CAAT's initial focus was on establishing a
small grants programme, through which it
has funded the development of new in vitro
systems, and of assays that could ultimately
be used for product safety testing, by fundamental research scientists. Over the years,
CAAT has become a visible advocate of the
Three Rs, and it fulfils a unique role in the
USA in liaising with scientists from academia, industry and governmental organisations. In this capacity, CAAT has organised
regular scientific symposia and has played a
major role in bringing together diverse
groups to formulate a framework for the validation of alternative methods for product
safety testing (18).
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During the early 1980s, the campaigns
against the Draize and LD50 tests, and
simultaneous attempts to pass legislation in
the USA to promote the use of alternatives,
focused industrial and congressional attention on alternative methods. Public pressure
led to the revision and strengthening of the
US Animal Welfal'e Act and the Public
Health Service Policy on the Humane Care
and Use of Labol'ato;y Animals (191, both of
which incorporated the requirement that
consideration be given to the Three Rs
before any research involving the use of animals was started. The concept of alternatives
was also promoted via legislation relating to
the role and activities of the National
Institutes of Health (NIH),
In 1986, a report by the US Congress
Office of Technology Assessment on
Alternatives to Animal Use in Research,
Testing a.nd Educa.tion (20) provided evidence of the broad scope and potential of the
Three Rs concept of alternatives and, in the
same year, the Health Research Extension
Act gave legislative force to the revised
Public Health Service Policy on animal
research. In Europe, the European Research
Group for Alternatives in Toxicity Testing
(ERGATT) was also established in 1986.
A set of International Guiding Principles
for Biomedical Research Involving Animals
were published in 1985 (21); the basic principles are outlined in Table 1. Thus, by the end
of the 1980s, new laws were in place in vari·
ous parts of the world, which not only recognised Russell and Burch's concept, but
placed legal and moral obligations on all concerned to seek to replace, reduce andlor
refine laboratory animal experimentation
wherever possible. Full implementation of
these laws and the development of replace·
ment alternatives became the next chal·
lenges.
In 1993, the US NIH Revitalization Act
included statements drafted and supported
by animal protection organisations and by
several large corporations which promote the
concept of alternatives. In particular, the Act
authorised the establishment of an Applied
Toxicology Program within the National
Institute of Environmental Health Sciences
(NIEHS), which eventually developed into the
Interagency Coordinating Committee for the
Validation of Alternative Methods (ICCVAM).
At the same time, a group of scientists
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Table I:

International Guiding Principles for Biomedical Research Involving
Animals

1.

The advancement of biological knowledge and the development of improved means for
the protection of the health and well-being both of man and of animals require recourse
to experimentation on intact live animals of a wide variety of species.

II.

Methods such as mathematical models, computer simulation and in vitro biological systems should be used wherever appropriate.

III.

Animal experiments should be undertaken only after due consideration of their relevance for human or animal health and the advancement of biological knowledge.

IV.

The animals selected for an experiment should be of an appropriate species and quality,
and the minimum number required, to obtain scientifically valid results.

V.

Investigators and other personnel should never fail to treat animals as sentient, and
should regard their proper care and use and the avoidance or minimisation of discomfort, distress, or pain as ethical imperatives.

VI.

Investigators should assume that procedures that would cause pain in human beings
cause pain in other vertebrate species although more needs to be known about the perception of pain in animals.

VII. Procedures with animals that may cause more than momentary or minimal pain or distress should be performed with appropriate sedation, analgesia or anaesthesia in accordance with accepted veterinary practice. Surgical or other painful procedures should not
be performed on unanaesthetised animals paralysed by chemical agents.
VIII. Where waivers are required in relation to the provisions of article VII, the decisions
should not rest solely with the investigators directly concerned but should be made, with
due regard to the provisions of articles IV, V and VI, by a suitably constituted review
body. Such waivers should not be made solely for the purpose of teaching or demonstration.
IX.

At the end of, or when appropriate during, an experiment, animals that would otherwise
suffer severe or chronic pain, distress, discomfort, or disablement that cannot be
relieved should be painlessly killed.

X.
~

XI.

The best possible living conditions should be maintained for animals kept for biomedical purposes. Normally the care of animals should be under the supervision of veterinarians having experience in laboratory animal science. In any case, veterinary care
should be available as required.
It is the responsibility of the director of an institute or department using animals to
ensure that investigators and personnel have appropriate qualifications or experience
for conducting procedures on animals. Adequate opportunities shall be provided for inservice training, including the proper and humane concern for the animals under their
care.

Taken from Howard-Jones, (21).
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from key regulatory agencies in the USA
established the Interagency Regulatory
Alternatives Group (IRAG; an ad hoc committee), to discuss the implementation of
alternatives in the regulatory sector.
In 1989, Alan Goldberg and Bert van
Zutphen decided to initiate a series of world
congresses devoted to alternatives and animal use in the life sciences (covering the
Three Rs in research, testing and education),
which were to be held every three years. The
first World Congress was held in Baltimore,
USA, in November 1993, and was attended
by 725 people (representing academia, industry, and government and animal protection
organisations) from 24 countries (22). The
second World Congress is to be held in
October 1996 in Utrecht, in The
Netherlands, while a third World Congress,
to be held in Italy in 1999, is already being
planned.
It is clear that significant changes have
occurred in the planning and conduct of biomedical research projects. In Great Britain,
where reasonably accurate statistics on animal use are available, the data indicate that
the use of animals increased by an average of
6% per year between 1937 and 1971, to a
total of over 5.5 million (23). From 1972 to
1978, the number of animals used remained
relatively stable, and then animal use began
to decrease by an average of 5% per year
from 1979 onwards. The increase in animal
use was driven largely by the search for new
drugs and the expansion of the pharmaceutical industry. Since the mid-1970s, the use of
animals in commercial, government and university/hospital laboratories in Britain has
dropped by 65%, 56% and 26%, respectively.
In The Netherlands, total animal use has
declined by 50% since 1978 (24). While the
data for the USA are less reliable, it has been
argued that animal use has also decreased
significantly in American laboratories,
despite funding for biomedical research having increased during this period (25).
In the mid-1990s, the question we face is
whether there will be a revolution in thinking and practice, which is what is needed if
the expectations of Hume, Russell, Burch,
Lane-Petter, Medawar, Stevens, and all the
others involved in the original UFAW project, are to be met, and the principles of
humane experimental technique are to be
brought fully and effectively into operation.
Much has been achieved, but there is still

considerable room for progress and improvement.

Scientific and Ethical Justification
All proposed use of laboratory animals
should be subject to review, to determine
whether such use appears to be scientifically
and ethically justifiable. In some circumstances, the "alternative" may simply be not
to undertake the animal procedure at alL
Where the necessity of conducting certain
animal procedures cannot be justified sufficiently on scientific or ethical grounds, the
project proposal should be rejected.
Guidelines have been prepared to assist
review committees in assessing whether
alternatives have been adequately considered (26).
In their consideration of the ethics of
using animals in biomedical research, a
Working Party of the Institute of Medical
Ethics (UK) concluded that "a research project involving animal subjects should take
place only when it can be shown:
a) that the aim of the project is worthwhile;
b) that the design of the project is such that
there is the strong possibility that it will
achieve the aim;
c) that the aim could not be achieved using
morally more-acceptable and scientifically no less-acceptable alternative subjects and procedures; and
dl that the likely benefits of the project are
substantial enough in relation to the suffering likely to be caused to the animals
used (that is, the likely benefits of the
research should be 'weighed' against the
'costs' to the animals involved)"(27).
It is these four main points, which include
the need to consider the potential for using
alternative methods, which should be
addressed to the satisfaction of the reviewers
(who generally include biomedical scientists,
veterinarians, ethicists, and community representatives with an interest in animal protection).
The UK system involves licensing specific
persons both with respect to the projects to
be undertaken and for their personal use of
laboratory animals (28). It provides a comprehensive and vigorous system of controls
when taken together with the formal certifi·
cation (designation) of heads of establish-
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ments where experimental animals are used
and the common species are bred. The
Animals (Scientific Procedures) Act 1986 also
provides for the appointment of inspectors in
the Home Office (the government departM
ment equivalent to the ministry of internal
affairs in other countries). Home Office
Inspectors check all designated establishments to ensure compliance with, or to
report on non-compliance with, the 1986 Act,
or with the terms and conditions of licences
or certificates issued under the Act.
Uniquely in Britain, individual Home
Office Inspectors statutorily review projects
and protocols, and advise the Minister (in
practice, his officials) on the costs versus
benefits, with the aim of ensuring that only
properly justified work is licensed; these are
functions performed by ethics review committees in other countries. Where appropriate, views on proposed research projects are
sought from other Inspectors and, occasionally, from external assessors or the APC.
Some special categories of work are mandatorily referred to the APC, for example, work
with primates and on cosmetics, and applications to use animals for microsurgical training. Home Office Inspectors only make
recommendations to government officials
but, in practice, their advice is usually
accepted. Inspectors have almost no formal
enforcement or executive powers with regard
to licensees, but can order the immediate
humane killing of animals they consider to
be suffering excessively. Experimenters
rarely disregard the views of Home Office
Inspectors on the extent to which practical
outcomes match the detailed protocols
authorised by project licences.
In Germany, the Department of
Agriculture, which is responsible for animal
protection, adopts the general philosophy
that, even if it is more expensive to use a
non-animal method than to conduct an animal procedure, a lower cost is not sufficient
justification for using animals. However, in
1994, the highest constitutional court in
Germany ruled that an animal experiment
which is scientifically justifiable cannot be
prohibited for ethical reasons, interpreting
this to be in compliance with both the
national
legislation
and
Directive
86/609/EEC.

In The Netherlands, the performance of
animal experiments is not permitted unless
the protocol has been reviewed and approved
by an AEC. According to the proposed revi-
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sion of the 1977 Act on Animal
Experimentation, the chairperson and at
least two other members of such a committee
must be independent (that is, they must not
have a working relationship with the institutions for which the protocol is reviewed).
Furthermore, the AEC must also include
experts on ethics and on alternative methods, and the composition of the committee
must be approved by the National
Committee on Animal Experimentation. The
main tasks of an AEC are to evaluate
whether the expected benefit of the proposed
experiment outweighs the likely suffering of
the animals concerned. and to ascertain that
the feasibility for implementing the Three Rs
has been adequately taken into account
when preparing the protocol. AECs are also
required to evaluate the competence of the
persons involved in the design and performance of the experiments. Rejection of a proposed research protocol by the AEC can only
be overruled by the National Committee on
Animal Experimentation.
In the USA, under both the Animal
Welfare Act amendments of 1985 (regulations approved in 1989) and the Public
Health Service revised policy, Institutional
Animal Care and Use Committees ([ACUCs)
are required to review and approve all animal research proposals before the research is
allowed to proCeed. The IACUCs are
expected to ensure that approved animal
research protocols are worthwhile, that they
use the minimum number of animals necessary, that animal pain and distress are minimised, and that, in any procedures likely to
cause animal pain and distress (whether or
not anaesthetics or analgesics are used).
principal investigators document that they
have established "that alternatives were adequately considered"(29).
While the manner in which IACUCs pursue their duties varies, the inspectors enforcing the Act have paid particular attention to
the requirement that investigators document the lack of alternatives, and to the section of the regulations which reads:

"Research facilities will be held responsible if
it is subsequently determined that an alternative procedure was available to accomplish
the objectives of the proposed experiment ...
or if it is subsequently determined that an
experiment is unnecessarily duplicative and
that a good-faith review of available sources
would have indicated as much."
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As a result, the consideration of alternatives
in the USA, while not necessarily embraced
enthusiastically, is becoming routine during
the preparation of research proposals.

Selection of Appropriate Animals
In whatever country the research is to be
conducted, in designing a project the investigator should first consider whether the aims
of the project could be realised by using in
vitro techniques or less sentient animal
species, such as insects or nematodes. The
replacement of one animal species with
another, particularly if the species which is
then used is non-vertebrate, could also be
considered to be an alternative method (30).
Therefore, the model selected should be the
lowest phylogenetic species, and also the
least sentient species, which will allow the
scientific objectives to be realised. If the use
of living vertebrates is considered to be
essential, the aim should be to use the minimum possible number of animals (see the
section on Reduction Alternatives), and to
use strategies which will ensure that the animals which must be used are subject to the
minimum discomfort (see the section on
Refinement Alternatives).
A variety of strains of certain species are
available. For example, over 400 inbred
strains of mice and over 200 inbred strains of
rats have been developed. These provide a
wide range of phenotypes which are of potential value in many areas of research. The
choice of strain for a particular project
should largely be governed by a knowledge of
its characteristics, and by the need to control
phenotypic variability. In most cases, isogenic (inbred or Fl hybrid) animals are more
suitable than outbred stocks, because of
their high phenotypic uniformity, long-term
stability, identifiability, and detailed background information on their characteristics
(31).

However, in biological assays against standards (where phenotypic uniformity is especially important), although Fl hybrids are
usually more uniform than inhreds, there
are no a priori grounds for choosing the most
suitable strain or cross for a particular assay,
and further studies of the type described by
Hendriksen et al. (32) should be undertaken,
preferably as part of ongoing studies to minimise the number of animals which are used

for each assay and the degree of discomfort
caused by current assay procedures.
Where uniformity is important, it can also
be promoted by controlling the environment
in which the animals are reared and used. As
Chance discovered many years ago (reviewed
in Russell & Burch 1211, this does not mean
keeping the environment uniform and constant in all respects, but rather keeping it
uniform, constant and appropriate in certain
key respects. Reduction here generally coincides with the concept of refinement. For
example, as described by Fox (33), "handling
weanling female rats for three days prior to
experiments using the Steelman-Pohley
method of follicle-stimulating hormone assay
reduced the variability of their response", so
that "about twice as many non-handled rats
would be required in an assay to obtain the
same degree of precision as with handled
rats".

Reduction Alternatives
The term reduction alternatives describes
methods for obtaining comparable levels of
information from the use of fewer animals in
scientific procedures, or for obtaining more
information from a given number of animals,
so that, in the long run, fewer animals are
needed to complete a given research project
or test.
The greater the number of animals used in
an experiment, the greater will be the overall
costs, in terms of animal suffering (27l.
Thus, the number of animals used should be
the minimum which is consistent with the
aims of the experiment. However, past experience in the area of regulatory toxicity testing, for example, suggests that laboratory
animal welfare considerations and common
sense do not always prevail (for example, in
LD50 testing; 341. Saving of time or personal
convenience, or other non-scientific reasons,
are not sufficient justification for using more
animals than the minimum necessary to
obtain meaningful results. Proper statistical
design, prior to undertaking the study, and
appropriate analysis of the resulting data,
may make it possible to obtain .results of
comparable precision by using fewer animals.
The precision of an experiment depends
mainly on the sample size and the "error"
variance and not on the body weight of the
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test animal. The use of more animals on the
grounds that they are smaller and less
expensive is not scientifically justifiable. If a
test has to be conducted in a rodent and in a
non-rodent species and the test guideline
specifies the use of four dogs, then the use of
more than four rats cannot be scientifically
justifiable. It is recognised that problems
with a protocol may be encountered once the
experiment is under way. To prevent the
continuation of unsuccessful animal experiments without review, acceptable limits for
failures in protocols, and the actions to be
taken if these occur. should be specified.
Careful attention should also be given to
the type of endpoint to be used. Qualitative
endpoints (for example, dead/alive) often
involve severe animal pain and distress, and
generally provide less information than do
quantitative measurements.

Research strategy

Relatively little consideration has been given
to research strategy f';ince Russell and Burch
(2) discussed the random screening ofpoten~
tial new pharmaceutical agents under this
heading. Such screening is now largely done
by using in vitro systems, which is one reason for the decrease in the numbers of animals used in the last decade. However,
research strategy is also important in other
contexts. In particular, it may be necessary
to carry out small pilot studies which can be
reviewed before committing animals and
resources to major experiments. The statistical guidelines developed by Muller et ai. (35),
which include a detailed discussion of possible research strategies, should be brought to
the attention of biomedical investigators.

Experimental design and statistics
Optimum experimental design and statisticaL considerations may suggest that a particular protocol employs an insufficient number
of animals, and that more are needed to provide a satisfactory answer to the question
being posed. However, this should still lead
to an overall reduction in animal use, since
experiments which use too few animals will
generally not achieve their desired objectives, and will frequently need to be repeated
with a larger number of animals.

Regulatory tests
International harmonisation of protocols in
regulatory testing should lead to an overall
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reduction in the use of animals, provided
that there is a reasonable compromise on
acceptable sample sizes. Such harmonisation
should provide an opportunity to review the
design and sample sizes required in regulatory experiments, since, in some cases, sample sizes appear to have been decided in an
arbitrary manner, without taking statistical
considerations into account. Where possible,
the requirements should be formulated in
terms of acceptable confidence intervals,
rather than by specifying the numbers of
animals needed, so that where greater control of phenotypic variation is possible, the
number of animals can be reduced.
Efforts at international harmonisation
should target not only the protocols for partinliar tests, but also the specific requirements for those tests. This would reduce the
numbers of animals used by minimising the
array of tests required.

Non-regulatory experiments
There is evidence that poor experimental
design and inappropriate statistical analysis
of experimental results is leading to inefficient use of animals and of scientific
resources in toxicological research (36-38).
This is in agreement with previous studies of
statistical methods used in other areas of
biomedical research (37-41). However, more
investigation is needed to determine whether
appropriate experimental design and statistical analysis are employed in other areas of
research, such as experimental surgery,
pharmacology, biochemistry, experimental
immunology, and microbiology.
In some cases, the level of statistical
expertise appears to be so low that investigators are either unaware of the potential
value of obtaining statistical advice, or they
are unable to obtain appropriate statistical
advice, because there are so few biometricians with experience in their field of interest.
The "named statisticia.n"
In some countries, a "named veterinarian"
must be appointed to supervise some aspects
of laboratory animal welfare. In view of the
importance of good experimental design and
appropriate statistical analysis in underpinning high quality research, and the potential
savings in terms of the numbers of animals
which are used, consideration should be
given to the need for a full-time or part-time
"named statistician" to be associated with
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research facilities. This statistician would
undertake to be available to all investigators
who needed advice on experimental design
and statistical analysis of experimental data,
and possibly would have some statutory
obligation to' meet regularly with investigators to discuss current research projects.

Education in statistics
A basic understanding of experimental
design and statistics is necessary for all scientists. For investigators with no previous
training in statistics, this level of expertise
can probably be obtained from a course
involving the equivalent of about 30 hours of
lectures and associated practical work.
However, an equivalent level of expertise
could also be obtained by reading and by
using computer-assisted learning techniques. Books by Cox (42) and Cochran &
Cox (43) provide a good introduction to
experimental design; Cohen (44) deals specifically and in detail with the problem of determining the appropriate size for an
experiment. There are many texts on statistical methods, which can be used both for
learning purposes and as reference books
(45-48). There is also a need for some biomedical research workers to have a more
detailed training in biometrics/statistics, so
that they can act as consultants to other
investigators in their own institutes.
Refinement Alternatives

Refinement alternatives encompass those
methods which alleviate or minimise poten:
tial pain and distress, and which enhance
animal well-being. "Distress" is an aversive
state in which an animal is unable to adapt
completely to stressors and the resulting
stress, and therefore shows maladaptive
behaviour (49), The stressors may induce
physiological, psychological or environmental stress. "Pain" results from potential or
actual tissue damage, such as that caused by
injury, surgery or disease, and can lead to
distress. These terms and concepts have
been defined and discussed previously
(49-51).
Pain and distress can result from both
experimental and non-experimental causes.
Potential sources of experimental pain and
distress include: improper or prolonged
restraint, experimental infections, chemicalinduced toxic effects, surgical and experi-
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mental procedures, post-operative pain, and
improper euthanasia techniques. Non-expE>rimental sources include: naturally occurring
infectious and non-infectious diseases. suhoptimal environmental conditions, improper
handling, stressful housing situations (for
example, social isolation, barren cages or
pens), injuries sustained during fighting. and
injuries associated with the housing or
caging.
Much potential pain and distress can be
avoided or at least alleviated with the proper
use of anaesthetics, analgesics and tranquilisers, which is a critical component of
any comprehensive programme of adequate
veterinary care. Such a programme provides
for frequent observation of the animals by
trained veterinary staff, to detect and appropriately relieve pain and distress. However, a
substantial number of animals used in
research and testing experience unrelieved
pain or distress. All experimental protocols
should be sufficiently detailed with regard to
the type and severity of likely adverse
effects, the times of peak occurrence,
humane endpoints, and the remedial actions
to be taken.
In The Netherlands, a serious attempt has
been made to categorise animal experiments
on the basis of the severity of pain and distress experienced. In 1993, 51.47< of the animals were reported to have experienced
either no or minor discomfort, 26. Fk experienced moderate discomfort, and 22.51}(· experienced severe discomfort (with a fifth of
these receiving drugs to prevent or relieve
the pain or distress; 24),
The percentage of animals experiencing
unrelieved pain and distress from non-experimental causes is not known. Recent
advances in science and technology, and in
laboratory animal medicine, offer significant
opportunities to develop alternative methods
which may further reduce or eliminate unrelieved pain and distress. It is proposed that
research, testing and education facilities are
encouraged to improve and optimise the
well-being of laboratory animals, for example, by:
a) The procurement and maintenance of
animals free of pathogenic organisms;
this requires effective vendor surveillance, quarantine, health monitoring,
disease investigation and preventive
medicine programmes.

849

M. Balls et ai.

b) The provision of optimal caging and husbandry procedures (appropriate to the
physiological and behavioural needs of
the species), such as avoiding caging animals singly whenever feasible and practical.
c) The provision of optimal environmental
conditions, with minimal variations in
temperature, humidity, etc.
d) The provision of enrichment/exercise
programmes where they are appropriate
and will be beneficial.

and aggressively disseminated (52).

Need for a.ssessment measures of animal pain
and distress
At present, we do not have a convenient and
standardised way of objectively assessing
animal pain and distress. Rather, the assessment is generally based on subjective clinical
signs of abnormal behaviour and appearM
ance. The approach to animal pain and distress is to assume that a procedure which
inflicts pain and distress in human beings
will inflict at least as much pain and distress
in animals, unless there is evidence to the
contrary (52, 53).
There are wide variations among different
countries with respect to assessments of the
extent of pain and distress caused by partic M
ular
husbandry
and
experimental
approaches. There are no internationally
defined standards on animal pain and disM
tress or agreed cut-off points, although some
working guidelines have been produced and
disseminated widely (for example, 54). There
are a number of specific national guidelines
on procedures which cause particular concern, such as those on cancer research proM
duced by the UK Coordinating Committee on
Cancer Research (55), on antibody production (56), and on lethal endpoint screening
tests for antimicrobial agents (57). The number of techniques or scientific procedures
that are commonly used and are of signifi M
cance probably amount to no more than one
or two hundred.
Before adverse effects on animals can be
assessed, one must be able to recognise such.
effects via either behavioural or physiological
measures. Several such measures have been
suggested (for example, 58-60), but have not
been widely adopted. In order to prioritise
which husbandry and experimental procedures need to be refined and modified, appropriate objective measures of adverse effects
on animals need to be developed, validated

Very little research funding is available to
support efforts to investigate and refine
experimental techniques and scientific procedures. Some ad hoc funding has supported
workshops on antibody production, adjuvant
use and infectious disease models. The BVA
Animal Welfare Foundation, FRAME, the
RSPCA and UFAW formed a Joint Working
Group on Refinement in 1989, with the
intention of setting up a series of workshops
to discuss ways in which common laboratory
procedures could be refined. The first and
second reports were on the removal of blood
from laboratory mammals and birds (61) and
on refinements in rabbit husbandry (62),
respectively. Nevertheless, no sustained
source of funding is available to support the
relatively modest research projects which
could provide th~ impetus to develop an
appropriate measure 9f adverse effects on
animals, and which could provide essential
data on the actual impact of particular scientific procedures and experimental techniques. Some research funding is available to
support animal husbandry modifications and
environmental enrichment (especially for
primates, dogs and cats), but there is little
funding available to explore environmental
enrichment in rodent housing, despite the
fact that rodents constitute 85% of all laboratory animals used in experiments.

International harmonisation
Attitudes differ as to which scientific procedures lead to animal pain and distress, and
the severity of the pain and distress they
cause. Efforts to identify these differences, to
determine the underlying reasons for them,
and to harmonise international standards as
much as possible should be undertaken.
Research support for refinement alternatives

Dissemination of information on refinement
alternatives
Scientists are not sufficiently aware of the
concept of refinement alternatives and, in
general, they do not recognise the importance of refinement in their research. The
concept of recognising, minimising and eliminating pain and distress in laboratory animals should be included in training
programmes for all persons involved in the
care and use oflaboratory animals. Details of
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research facilities. This statistician would
undertake to be available to all investigators
who needed advice on experimental design
and statistical analysis of experimental data,
and possibly would have some statutory
obligation to· meet regularly with investigators to discuss current research projects.

Education in statistics
A basic understanding of experimental
design and statistics is necessary for all scientists. For investigators with no previous
training in statistics, this level of expertise
can probably be obtained from a course
involving the equivalent of about 30 hours of
lectures and associated practical work.
However, an equivalent level of expertise
could also be obtained by reading and by
using computer-assisted learning techniques. Books by Cox (42) and Cochran &
Cox (43) provide a good introduction to
experimental design; Cohen (44) deals specifically and in detail with the problem of determining the appropriate size for an
experiment. There are many texts on statistical methods, which can be used both for
learning purposes and as reference books
(45-48). There is also a need for some biomedical research workers to have a more
detailed training in biometrics/statistics, so
that they can act as consultants to other
investigators in their own institutes.
Refinement Alternatives

Refinement alternatives encompass those
methods which alleviate or minimise poten:
tial pain and distress, and which enhance
animal well-being. "Distress" is an aversive
state in which an animal is unable to adapt
completely to stressors and the resulting
stress, and therefore shows maladaptive
behaviour (49). The stressors may induce
physiological, psychological or environmental stress. "Pain" results from potential or
actual tissue damage, such as that caused by
injury, surgery or disease, and can lead to
distress. These terms and concepts have
been defined and discussed previously
(49-51).
Pain and distress can result from both
experimental and non-experimental causes.
Potential sources of experimental pain and
distress include: improper or prolonged
restraint, experimental infections, chemicalinduced toxic effects, surgical and experi-
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mental procedures, post-operative pain. and
improper euthanasia techniques. Non-experimental sources include: naturally occurring
infectious and non-infectious diseases. suhoptimal environmental conditions, improper
handling, stressful housing situations (for
example, social isolation. barren cages or
pens), injuries sustained during fighting. and
injuries. associated with the housing or
caging.
Much potential pain and distress can be
avoided or at least alleviated with the proper
use of anaesthetics, analgesics and tranquilisers, which is a critical component of
any comprehensive programme of adequate
veterinary care. Such a programme provides
for frequent observation of the animals by
trained veterinary staff, to detect and appropriately relieve pain and distress. However, a
substantial number of animals used in
research and testing experience unrelieved
pain or distress. All experimental protocols
should be sufficiently detailed with regard to
the type and severity of likely adverse
effects, the times of peak occurrence,
humane endpoints, and the remedial actions
to be taken.
In The Netherlands, a serious attempt has
been made to categorise animal experiments
on the basis of the severity of pain and distress experienced. In 1993, 51.4'7r of the animals were reported to have experienced
either no or minor discomfort. 26.1(Yr- experienced moderate discomfort. and 22.50'r· experienced severe discomfort (with a fifth of
these receiving drugs to prevent or relieve
the pain or distress; 24),
The percentage of animals experiencing
unrelieved pain and distress from non-experimental causes is not known. Recent
advances in science and technology, and in
laboratory animal medicine, offer significant
opportunities to develop alternative methods
which may further reduce or eliminate unrelieved pain and distress. It is proposed that
research, testing and education facilities are
encouraged to improve and optimise the
well-being of laboratory animals, for example, by:
a) The procurement and maintenance of
animals free of pathogenic organisms;
this requires effective vendor surveillance, quarantine, health monitoring,
disease investigation and preventive
medicine programmes.
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Replacement Alternatives

refinement and animal welfare considerations should routinely be included in scientific papers and publications (63).
Refinement alternatives have multiple benefits, and the promotion of their implementation should include the publication of
appropriate review articles which document
the scientific, economic and humane benefits.
There is no readily available up-to-date
knowledge base on refinement. Techniques
that are developed to refine a procedure are
frequently not reported in the scientific literature, or are established simply as Standard
Operating Procedures (SOPs) within an
institution. To establish "best practice"and
to advance the implementation of refinement
alternatives, it is important to share such
experience, data and SOPs. Sharing of data
and theories is normally accomplished via
the scientific literature, but there has been a
marked lack of opportunity to discuss and
provide information on refinement alternatives in the main biological journals.
Since the pioneering work of Chance (64),
there have been several publications on the
assessment of distress and refinement procedures (2, 33), which should be made as
widely known as possible (65-67). In particular, experimenters should be familiar with
the important general survey by Claassen
(68). As pointed out by Gardner & Gardner
(69), acceptance of the very real need for
more research in distress assessment and
refinement should not discourage us from
,making urgently needed immediate improvements in cases where there are obvious physiological or behavioural indications of stress,
and therefore of distress, due to factors such
as overcrowding, social isolation or restraint.

Replacement alternatives encompass those
methods which permit a given purpose to be
achieved without conducting experiments or
other scientific procedures on animals.
Russell & Burch (2) distinguished between
relative replacement, for example, the
humane killing of a vertebrate animal to provide cells, tissues and/or organs for in vitro
studies, and absolute replacement, in which
animals would not need to be used at all, for
example, the culture of human and invertebrate cells and tissues.
It was discussed whether animal organatypic and primary cell culture should be
classed as reduction, since an animal would
still have to be used, whereas serial cell culture, for example, the use of permanent cell
lines, would be classed as replacement. It
was thought to be preferable to continue to
use Russell and Burch's approach, partly
because the use of different terms for nonhuman vertebrate primary cultures on the
one hand, and human and invertebrate primary cultures and non-human vertebrate
serial cell cultures on the other, would lead
to confusion, and partly because the humane
killing of an animal does not represent an
experiment or a regulated scientific procedure in most countries.
Nevertheless, statistics on ~nimal use
should include the numbers of animals killed
specifically for the purpose of providing cells
and tissues for in vitro studies, and for the
production of subcellular fractions, such as
liver S9 preparations for use in metabolism
and mutagenicity studies. Account should
also be taken of the culling of animals surplus to requirements, which can be very high
in the breeding and supply of rodents.

Auditing system

Replacement alternative methods and
approaches

Auditing of the implementation of refinement alternatives at the institutional level is
rarely carried out, although it can easily be
done by requiring investigators to provide
basic information for review by ethics committees/IACUCs, or by independent review
by animal welfare officers, laboratory animal
veterinarians, or government inspectors.
Such data can significant.ly enhance the
development of further refinements, and
raise awareness of the concept of refinement
and its importance.

The range of replacement alternative methods and approaches includes the following
(27, 70, 71):
a) The improved storage, exchange and use
of information about animal experiments
already carried out, so that unnecessary
repetition of animal procedures can be
avoided.
bl The use of physical and chemical techniques, and of predictions based on the
physical and chemical properties of molecules.
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c) The use of mathematical and computer
models, including: i) modelling of quantitative structure-activity relationships, i.e.
taking advantage of correlations between
molecular structure and biological activity
in the prediction of the potential desired
and undesired effects of series of related
chemicals; ii) molecular modelling and the
use of computer graphics, for example in
actively designing drugs and other chemicals for specific purposes; and iii) modelling
of biochemical, physiological, pharmacological, toxicological and behavioural systems and processes.
d) The use of "lower" organisms with limited
sentience and/or not protected by legislation controlling animal experiments,
including invertebrates, . plants and
microorganisms; for example, the use of
bacteria in genotoxicity testing.
e) The use of the early developmental stages
of vertebrates before they reach the point
at which their use in experiments and
other scientific procedures is regulated.
D The use of in vitro methods, including subcellular fractions, short-term maintenance
of tissue slices, cell suspensions and perfused organs, and tissue culture proper
(cell and organotypic culture), including
human tissue culture.
g) Human studies, including the use of
human volunteers, post-marketing surveillance and epidemiology; for example, sldn
patch testing in humans before marketing,
and monitoring consumer response after
marketing, as alternatives to the animal
testing of cosmetic products.
In many areas of the biomedical sciences, in
vitro methods are increasingly used as the
methods of choice in place of animal studies,
not because they provide precisely the same
information, but because they offer the best
scientific approach to tackling the questions
being asked. An example of this would be the
use of tissue, cell and subcellular preparations
in vitro for screening candidate compounds for
pharmacological activity. The information provided by the in vitro methods may ultimately
have an outcome similar to that provided by
the animal studies used in the past (for example, the identification oflead compounds).

Replacement alternatives in research and
testing
A distinction also needs to be made between
the replacement of animal use in fundamen-
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tal biomedical research and in regulatory
testing (72), In the former case, scientific
methodology evolves mainly through an
informal publication and peer-review acceptance and/or improvement process. In the
latter case, however, formal validation of the
replacement alternative method in terms of
its relevance and reliability for its stated purpose is likely to be necessary (18, 73), since
national or international laws, guidelines or
regulations will need to be modified, if the
non-animal test is to gain wide acceptance as
a replacement for the animal test. In addition, as practised at present, regulatory testing often requires the induction of adverse
effects, and even of considerable animal suffering, which are integral to the test procedure and are therefore unavoidable.
It follows from this that those of us who
are concerned that the Three Rs concept
should be implemented as fully as possible,
should welcome the trend toward the use of
non-animal methods in fundamental
research. However, in the case of regulatory
efficacy and toxicity testing, research specifically aimed at providing validated replacements for the currently accepted animal test
procedures and testing strategies should be
conducted, and the value of such research
should be recognised by the scientific community at large. This would be fully consistent with one of the hopes expressed by
Russell and Burch in the conclusion to their
book, i.e. that their efforts "would stimulate
some experimentalists to devote special
attention to the subject"(2).
A great deal of effort is being put into the
development and evaluation of replacement
alternative methods for use in testing, by
industry and academia, often with the financial support of animal welfare organisations
and/or government funds specifically earmarked for this purpose. Until now, the rate
of progress has been slow, partly because a
series of barriers must be overcome, in addition to the legislative/regulatory barrier
referred to earlier (74). The most important
of these are the validation barrier and the
scientific barrier.

The validation barrier
The validation of new tests and testing
strategies in terms of assessing their relevance and reliability is difficult, and the hurdles placed in the path of replacement
alternatives must necessarily be high, if mistakes are to be avoided which could have dis~
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astrous human health and environmental
consequences and thus delay the achieve·
ment of our objectives (75). However, these
hurdles must be fair, especially as the animal tests we are seeking to replace have not
themselves been subjected to formal, independent and objective evaluation in terms
of their relevance, reliability and applicability. Validation should be seen as a continuOllS process, and the principles and criteria
involved and the correct practices to be followed are still being debated (18, 73, 76),
One of the greatest problems in planning
validation studies in the area of toxicity
testing is finding in vivo data of sufficiently
high quality for use in evaluating the predictive value of the results obtained in in
vitro tests. This has led to recommendations
that an International Reference Chemical
Data Bank be established 06, 77), to provide open-access listings of chemicals,
backed by first-class toxicological data
reviews, safety advice and a source of chemicals of known purity. The European Centre
for the Ecotoxicology and Toxicology of
Chemicals (ECETOC) has established task
forces for providing chemicals for use in validation studies on alternatives to the Draize
eye and skin irritation/corrosivity tests (for
example, 78). The US National Toxicology
Program (NTP) publishes the results of all
of its studies, both electronically on the
Internet and in book form.
Of course, the most appropriate way to
assess a new in vitro method is not necessarily to use in vivo data from laboratory
animals as the reference standard, but to
compare results from both methods to those
obtained in human (clinical) studies.
Unfortunately, finding human data of sufficient quality is a major problem, and those
data which do exist are often proprietary.
Moreover, generating new human data is
fraught with ethical and logistical considerations.

The scientific barrier
Replacement alternative methods must be
based on good science, and extravagant
claims which cannot be substantiated must
not be made about them. One of the most
fascinating sections of Russell and Burch's
book is their discussion on the relative merits of fidelity and discrimination models (2).
High fidelity models, as exemplified by the

use of rodents and other laboratory mammals in toxicity testing, are used because
"in their general physiological and pharmacological properties" they are "more consistently like us than are other organisms".
High discrimination models, on the other
hand, "reproduce one particular property of
the original, in which we happen to be interested". The Limulus amoebocyte lysate
(LAL) test is one such model. The use of discrimination models in toxicity testing, for
example, is represented by the currently
available in vitro systems and other replacement alternatives, which are more suitable
for answering a specific question about the
mechanism of a toxic effect or toxic
response in a particular cell type than for
answering the more general question: «Is
this chemical likely to be toxic in ways
which we cannot envisage?"
Russell and Burch warned of the high
fidelity fallacy and of the danger of expecting discrimination in particular circumstances from models which show high
fidelity in other, more general, terms (2),
They pointed out that the fidelity of mammals as models for man is greatly overestimated, and concluded that the assumption
that "mammals are always the best models"
for man "is maintained with special stubborness in some special fields (such as that
of toxicity testing)". They went on to say
that the most important consequence of the
high fidelity myth is that it "ignores all the
advantages of correlation ", whereby "the
responses of two utterly different systems
may be correlated with perfect regularity",
despite other differences between them.
The argument about fidelity, discrimination
and correlation test systems is still going on
today.
Ultimately, there is only one way forward
- the development and acceptance of
replacement alternatives for both research
and testing must be based on a sufficient
understanding of the molecular and cellular
mechanistic basis of what is being studied
or measured, i.e. on sound science. Hence,
the current trend toward a more mechanistic approach should be welcomed, ·encour~
aged and financially supported.
Several specific recommendations relating to the development and use of replacement alternatives in production and testing
are given at the end of this report (see
Conclusions and Recommendations).
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Education and Training
The successful implementation of the Three
Rs heavily depends upon the e~ucation at;d
training of those persons Involved. l~
research and testing. A distinction must InItially be made between "education" and
"training". Education is defined here as the
didactic presentation of the information and
theories of animal use that will contribute to
the development of proper attitudes toward
the use of animals in scientific procedures.
Training is defined as the acquisition ofpractical knowledge and skills directly associated
with animal handling and procedures. Both
education and training are necessary for the
implementation of all of the Three Rs.
.
The objective of the educatIOn and traming is to provide sufficient information to
allow scientists to conduct animal procedures to high standards of both science ~nd
animal welfare, following proper evaluatIOn
of the scientific and ethical considerations
which should govern the use of alliaborat?ry
animals. All people involved in performmg
animal experiments should have appropriate
practical training, to help ensure that they
are technically competent to carry out the
procedures. Most countries require that
those conducting animal research be competent and trained in the techniques that they
are using or plan to use. Training for those in
professions that require expe~tise in animal
handling should he accomplished through
apprenticeships (that is, "on-the-job" training) and, in such cases, animals sh?uld o~ly
he used in order to perfect speCIfic skIlls
which cannot be achieved in any other way.
The education and training should contribute to a scientist's ability to design experiments properly and to plan research
strategies, to become competent in ~ni~al
handling and the performance of sCIentIfic
procedures, to make decisions with re.gard to
the ethics of using animals in experIments,
and to determine whether alternatives are
available. The concept of refinement alternatives and the obligation to make them publicly ~vailable, should also be emphasised in
education and training programmes.
The workshop participants identified five
separate groups for which education and
training are necessary:
a) animal technicians;
b) scientists, including laboratory animal
veterinarians;
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c) directors of animal facilities and animal
welfare officers;
d) national and regional inspectors; and
e) members of ethics committees/IACUCs
(scientists and lay representatives).

Course content a.nd format
The type of education and training referred
to below is intended primarily for students
preparing for an advanced degree in biom~d
ical research. Such courses should emphaSise
that the aim of the training is to improve scientific quality as well as to educa~e scientists
with respect to the legal reqUlrem~nt for
using alternatives, whenever posslble. ~
description of the course on ammal experImentation and alternatives currently offered
at Utrecht University in The Netherlands
has been published recently (79). In addition,
the Federation of European Laboratory
Animal Science Associations (FELASA)
Working Group on Education in Europe, and
the National Research Council in the USA,
have published guidelines for the education
and training of persons working with lab~ra
tory animals (80, 811. All of these publications serve as excellent prototypes for the
development of courses in other countries.
There are several ways in which a course
on animal experimentation and alternatives
can be packaged. The first is the standard
written syllabus with accompanying reference materials (for example, 82).
Demonstration videos can also be used.
Other possible formats include interactive
CD-ROM and the Internet, the use of both of
which is becoming more widespread. These
latter two formats have the potential to
reach a greater number of scientists.

Education in ethology
It is clear that the progress of implementing
reduction and refinement alternatives
depends largely on the ability of scientists to
observe and understand the behaviour and
needs of their laboratory animals. At present it would seem that many experimenters
are ~s lacking in ethological equipment as
they are in statistical knowledge ..Fo: ex~n:
pie, many experimenters have an mdlscnmlnate reaction to work with mazes, some
regarding it as harmless and some as stressful. In fact, if a rat is put in a maze when not
particularly hungry, he is given an .interesting opportunity to exercise the speCIal talent
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of his species, that of making a cerebral map
of his spatial surroundings. Such a rat,
exploring the maze thoroughly, will learn it,
so that later, if the maze is altered, he can
soon spot new blind alleys or short cuts. If a
rat is put in a maze when severely hungry,
he will run it with anxiety and distress,
becoming conditioned to one route and stick·
ing to it thereafter, even when conditions are
changed and it no longer leads to reward.
These two cases have been used as classical
examples of relaxed and stressful behaviour,
respectively, by Russell (83).
One very useful guideline for mammalian
behaviour supplied by ethology is this: anything that leads to learning is harmless or
positively enjoyable; anything that leads to
conditioning involves some stress and, there·
fore, distress. A very effective short course in
ethological observation was designed some
years ago for medical students by Chance &
Mackintosh (84). It originally required the
use of two rats, but could easily be adapted to
a video.

Replacement alternatives in education
Students should not be forced to use animals
for any purpose. Replacement alternatives
for use in education have been described by
Fosse (85). These include models, films and
videotapes of procedures, interactive com·
puter programs, software simulations,
courseware on compact discs and interactive
laser discs, and virtual reality programs. The
NORINA database contains information on
those alternatives which are available (86).
Resources are required to produce these
materials and to make them more widely
available.

driven by political and social forces exclu·
sively, rather than being relevant to scien·
tilic issues (71). This is partly due to a lack of
appreciation of the basis of the Three Rs con·
cept as proposed by Russell and Burch, i.e.
that scientific excellence and the greatest
humanity in the use of laboratory animals
are inextricably linked, and of the great
potential value of alternative methods (87),
It also stems from a defensive attitude
among some scientists, perhaps resulting
from the campaigns of some antivivisection
organisations and from insufficient dialogue
among the scientific and animal protection
communities (88).
Scientists should be better informed about
the Three Rs concept, and should be encour·
aged to see it as an opportunity, rather than
as a threat. At the conclusion of their book,
Russell and Burch expressed the hope that
experimenters would be stimulated "to
devote special attention to the subject ... to
work in full awareness of its existence and
possibilities"(2L For some, including the par·
ticipants in this workshop, the Three Rs has
become a subdiscipline within the biological
sciences, but this is not generally recognised.
Such recognition should be encouraged and
promoted through scientific societies, acade·
mic journals and funding agencies. Various
governments have already given a lead, by
creating such bodies and centres as ECVAM,
ICCVAM and ZEBET, the German Federal
Government's Centre for Documentation
and Evaluation of Alternative Methods to
Animal .Experiments. The journals specifi·
cally devoted to the Three Rs, such as
AATEX, ALTEX, TAR and ATLA, should be
made more readily available to scientists by
their institutional libraries.

Informing Scientists about the Three
Rs Concept

Informing the General Public

The use of the term alternatives to encom·
pass all of the Three Rs is now widely
accepted in many countries, and is incorpo·
rated into the names of various centres, for
example, CAAT, ECVAM and the NCA, and
journals, such as AATEX (Alternatives to
Animal Testing and Experimentation Japan), ALTEX
(Alternativel! zu
Tierexperimenten - Switzerland), TAR (The
Alternatives Report - USA), and ATLA
(Alternatives To Laboratory Animals - UK).
However, some scientists see its use as being

Although many members of the general public are concerned about the use of animals in
research, testing and education, it is clear
that they are not typically well-informed
about the Three Rs approach to th~ ethical
issues raised by animal experimentation.
There are several reasons for this: the Three
Rs approach has not been embraced by many
of the protagonists in the vivisection contro·
versy (neither scientists nor animal protec·
tionists); some individuals and organisations
who have embraced the Three Rs have not
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made a point of informing the public of this
approach; and those who have made the
effort have often found the media unreceptive, preferring instead to portray confrontations between those holding diametrically
opposed views. Indeed, it is easier for all concerned to convey a message in the form of
simple slogans, such as Stop Animal
Experiments (89) or Most People See a RatWe See a Cure {or Cancer (90), than it is to
explain the principles of reduction, refinement and replacement as a blueprint for reeoncili ng the interests of science and animal
welfare.
Why should supporters of the Three Rs
consider informing the public about this
approach? Their efforts can reach members
of the public who are sympathetic, and who
can then offer moral, financial and political
support to the cause. We know that members
of the general public are hearing about more
confrontational approaches to the animal
research controversy; unless they also hear
about the Three Rs, our approach will be perceived as being irrelevant to this issue.
Many organisations concerned with promoting the Three Rs have sought to inform
the public about their activities, and about
the alternatives approach in general (for
example, 91 J. These efforts have entailed
producing leaOets, brochures and other written material (92); taking advantage of media
opportunities to appear on radio or television
programmes, or in print; speaking to students and community groups; and placing
advertisements. The Internet is providing
organisations with a new opportunity to
make their message widely and freely available. An unexplored possibility is for one or
more organisations to independently produce a high quality video programme, which
can be shown on educational television stations and be distributed to interested individuals and organisations.
Past efforts· to inform the general public
about the issues relating to alternatives have
had mixed outcomes. Accordingly, pro-alternatives organisations should devise and
implement such efforts carefully, with due
consideration to past successes and failures.
Perhaps the most important specific target audiences within the general public are
teachers and students in schools and colleges. In the UK, there has been a surge of
interest since animal experimentation
became a subject in secondary (high) school
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social studies and biology syllabuses. This
has led many organisations to produce special publications, and FRAME was invited by
an educational publisher to produce two
booklets to convey an objective, middleground position on animal experimentation
and on alternatives (93, 94). With the support of industrial companies, a copy of each
booklet was given free of charge to every secondary school in Britain. It is particularly
important that material for schools and colleges should be designed to help young people make up their own minds on this issue
(the approach adopted, for example, in the
newsletter GAATALYST, which is produced
by GAAT for 11-14 year olds), rather than to
seek to persuade them. In addition, while
more-detailed material might usefully be
provided for teachers, care should be taken
not to be seen to want to instruct them in
how to teach their subjects.
One very successful way for organisations
to encourage individual students to become
actively involved in the Three Rs is the provision of support for temporary employment
in laboratories or in the offices of the organisations themselves. Replacement alternative methods can be very suitable for
undergraduate, as well as graduate, research
projects.
There are occasions when concerted action
by groups of organisations with similar
philosophies and policies could be the best
way of getting a message across to a large
audience. For example, advertisements could
be placed in newspapers or magazines in the
light of specific events. Organisations which
were willing to join in such concerted actions
might also agree on a common logo, which
would become more widely recognised the
more it was used.

Special Considerations
Vaccines and other immunobiologicals
The development, production and quality
control of vaccines and other immunobiologicals was recognised as being an important
area for the implementation of the Three Rs,
since large numbers of animals are used
which usually suffer significant pain and dis·
tress as a result of the experimental proce·
dures employed. Most of the animal tests
undertaken are documented in either a com-
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pendium,
such
as
the
European
Pharmacopoeia, or in guidelines produced by
national control authorities and international regulatory bodies (for example, by the
World Health Organisation), as well as in
national product licences.
For a variety of reasons, interest in both
the Three Rs and in vaccine quality control
strategies has grown in the past decade. This
has led to a reduction in the use of animals
for vaccine quality control purposes. Reviews
of recent developments, and recommendations for further initiatives, have been published (95, 96).
Steps should be taken to facilitate further
implementation of the Three Rs concept
with respect to the development, production
and quality control of immunobiologicals,
especially in relation to testing requirements. Potency tests based on a challenge
procedure are of particular concern. Lethal
endpoint potency tests for tetanus and diphtheria vaccines are still documented in some
pharmacopoeias, and are therefore still performed in some countries, although alternative non-lethal endpoint tests are also
permitted and are widely used by more
advanced countries. Lethality endpoints
should be replaced with other assessment
measures. Validated in vitro test systems,
such as enzyme-linked immunosorbent
assays (ELISAs) or serological systems based
on in vitro models, should be employed, to
reduce and refine the use of animals. When
challenge of experimental anim.als is
unavoidable, clear clinical symptoms should
be taken as being equivalent to the lethality
endpoint, and animals showing such symptoms should then be killed humanely (951.
A proposed alternative approach for estimating potency (97) should be evaluated. In
this approach, a distinction is made between:
a) estimation of the immunogenic potency of
the first few batches obtained from a seed
lot; and b) monitoring the consistency of subsequent batches. The use of animals is limited to the first few batches, while
monitoring the consistency of the quality of
subsequent batches is undertaken by using
in vitro methods (971.
Although there is no in vitro model available for replacing the Abnormal Toxicity
Test in vaccine safety testing, the value of
this test is questionable, since its lack of
specificity hampers reliable interpretation of
the results obtained (95). Efforts should also
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be made to minimise the numbers of mice
used for pertussis vaccine testing by standardising the procedures employed.
It was emphasised that the development of
reduction, refinement and replacement
alternative methods is the responsibility of
all those involved in the production and quality control of vaccines and other immunobiologicals (that is, both industry and
governm€mt).
Transgenic animals
The production, breeding and lise of animals
genetically modified via the application of
transgenic techniques will undoubtedly
increase significantly in the future. This new
technology offers great potential scientific
benefit, in terms of the understanding of
fundamental biological processes, the
nature, diagnosis and treatment of various
diseases, the production of useful biological
products, and the husbandry of disease-resistant animals. Animal transgenesis may also
contribute to the implementation of the
Three Rs, by reducing animal numbers, by
permitting the replacement of more-sentient
species with less·sentient species, by reducing animal suffering in other ways, and by
increasing the relevance of laboratory animal use. For example, in the USA, several
transgenic mouse models are currently being
investigated by the NTP with respect to
their usefulness in evaluating the potential
carcinogenicity and mutagenicity of chemicals (98). Carcinogenicity studies employing
these models are completed in six months or
less, compared with the standard two-year
bioassay, and involve fewer animals per dose
group. In addition, the animals are not sub·
ject to age-related morbidity and mortality.
Despite these kinds of developments, some
observers are of the opinion that the use of
transgenic animals will lead to an overall
increase in animal use, rat-her than to a
decrease. There is also legitimate concern
that the control of the production, breeding
and use of transgenic animals is not adequately provided for in current legislation for
the protection of laboratory animals. For
example, there is as yet no broad agreement
on whether only the creation of transgenic
animals, andlor their breeding, and/or their
use in specific experiments should be treated
as regulated procedures, or whether transgenic animals should be protected throughout their lives, whether or not they are ever
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used in specific experiments. The system
adopted in the UK, whereby strict controls
are applied to the breeding of transgenics
until it can be shown that no special health
and husbandry problems are involved, is to
be recommended.
Molecular geneticists involved in produc~
ing transgenic animals must always be aware
of the animal welfare implications of their
experiments, and of their legal and moral
responsibilities (99, IDOl. Concern that this
is not always the case has been highlighted
by the occurrence of unexpected, sometimes
very severe, adverse effects in transgenic ani
mals. There are also ethical concerns about
transferring genes between species, particularly when the genes involved are human
genes (101). Moore & Mepham (102) have
suggested recently that the actual and potential implications of the increased use of
transgenic animals may result in the need
for a fundamental reappraisal of the mecha·
nisms whereby permission to perform scien·
tific procedures on animals is considered and
granted.
M

Special protection for selected animals
A fundamental tenet of the refinement prin·
ciple is that the least sentient species suit·
able for the proposed experimental work
should always be selected. However, there is
no general agreement on how sentience can
be measured or how degrees of sentience can
be compared. For example, is a marmoset
more sentient than a rat? In some legisla·
tion, 'Special consideration is given to non·
human primates, cats and dogs. In Britain,
this special consideration is also extended to
Equidae. It can be argued that there are two
different justifications for this approach.
Firstly, in the case of the higher primates
(Old World monkeys and Hominids), whatever is meant by "sentience" or, in the words
of Directive 86(609(EEC, "degree of neurophysiological sensitivity"(12), it is commonly
accepted that these animals are placed at the
top end of any spectrum or scale. They therefore deserve special consideration, both in
their own right, and also because, if we can·
not ensure the proper application of laboratory animal protection laws and regulations
to them, we are unlikely to be successful in
providing adequate care for rodents, birds
and fish.

Secondly, cats, dogs and horses have been
bred over many centuries to be companion
animals for human beings, and it can be
argued that, since they have been bred to be
dependent on us, we have a specific moral
obligation to them. That is certainly how the
vast majority of members of the general public would be likely to view the situation, and
both animal experimentation and the Three
Rs must be viewed in a social, as well as in a
scientific, context. Nevertheless, there is a
strong counter-argument that all laboratory
animals should be given equal protection,
and that all forms of speciesism should be
avoided.

Benefit and suffering!
It is implicit, if not explicit, in all the regulations governing laboratory animal use that
the purpose of the work must be worthwhile,
and that it must be viewed in relation to the
suffering caused to the animals used.
The British 1986 Act requires that the
likelihood of a beneficial outcome of a proposed programme of work is assessed in
advance, and that, where it would involve
vertebrate animals which might be caused to
suffer pain, distress and/or lasting harm, a
weighing of likely benefit versus likely suffering must be made, before permission is
given for the experimental work to proceed
(16,27, 103).
Cost-benefit apaIysis is part of our everyday lives, and it involves judgement on the
basis of evidence, rather than automatic
decisions based on precise measurements.
Applying this kind of approach should not be
new to scientists, since it is an essential part
of the peer· review system for granting
research funding.
Who should be involved in assessing and
weighing benefit and suffering will depend
on the particUlar system for regulating animal experimentation. The ultimate moral
responsibility should lie with the scientists
who propose to perform the studies.
However, institutions, funding agencies, governments and the community in general
should all have some input (27). In the UK,
the Home Office Inspector would discuss this
question with a project licence appJicant, and
would advise the Home Secretary, with
whom the ultimate legal responsibility lies

I The word "suffering" has been used as a generic term for "undergoing, experiencing or being subjected to pain,
distress and lasting harm n.
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(104). In other countries, IACUCs or animal ethics committees contribute to the
discussion or even make decisions.
This is a topic which deserves further
consideration, especially with respect to
the ways in 'which benefit and suffering
should be assessed and weighed. Four
main schemes have been proposed or are
in use: that suggested in Lives in the
Balance, the report of the Institute of
Medical Ethics (UK) Working Party (27);
the Dutch model developed by the
Department of Animal Problems, Leiden
University (105); a model proposed by
Porter (106); and the system already used
by the British Home Office Inspectorate
for the assessment and weighing of bene·
fit and suffering, which was described in
the 1993 report of the APC (107).
It is widely agreed that there are levels
of animal suffering which could never be
justified on scientific grounds, but there
is no agreement as to what those levels
are. It is certainly possible to perform
procedures in one country which would
not be permitted in another. This is a
matter which deserves urgent interna·
tional discussion and agreement.

The setting of targets
One way of making progress is to agree
that specific targets should be met, especially if a date for meeting a target is also
agreed. Whether or not a target is met,
the fact that it exists can influence policy
and stimulate action, as has been seen in
response to the Sixth Amendment
(Directive 931351EEC [108)) to the
European
Union
(EU)
Cosmetics
Directive, Directive 7617681EEC (109,
110).
In 1993, the Member States of the EU
agreed that everything possible should be
done to achieve a reduction of 50% in the
use of vertebrate animals for experimental
and other scientific purposes by the year
2000 (l1ll. It has also recently been suggested that agreement should be sought in
the EU on phasing out the use of nonhuman primates as laboratory animals by
the year 2005 (112). Further targets which
could be suggested would be an end to
potency and toxicity tests involving lethal
endpoints, to the use of the Draize eye
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irritancy test, and to all procedures which
result in substantially severe effects.

Concluding Remarks
The workshop participants unanimously
reaffirmed the principles put forward by
Russell & Burch (2), that humane science is
good science and that this is best achieved
by vigorous application of the Three Rs:
reduction alternatives, refinement alterna·
tives and replacement alternatives. Thus,
the only acceptable animal experiment is
one which uses the smallest possible number
of animals and causes the least possible pain
or distress which is consistent with the
achievement of a justifiable scientific pur·
pose, and which is necessary because there
is no other way of achieving that purpose.
Any proposed experiments on animals
should be subjected to prior and effective
expert review by an ethics committee or an
equivalent body. The Three Rs should be
seen as a challenge and as an opportunity
for reaping benefits of every kind - scien·
tific, economic and humanitarian - not as a
threat.
It was proposed that, if funds could be
obtained, an animal welfare information
unit for Europe should be established at
Sheringham, under the direction of Rex
Burch; this would liaise with the corre·
sponding centre in the USA. Such an initiative could help meet some of the specific
recommendations made in this report. as
well as playing an important role in the education of the general public.
It was agreed that contact would be maintained by the workshop participants, and
that a further meeting of the Sheringham
Group would take place on the occasion of
the Second World Congress on Alternatives
and Animal Use in the Life Sciences, to be
held in Utrecht in October 1996. One of the
principal aims of this meeting will be to
review the steps taken by the participants in
the workshop, individually and collectively,
to see that its report and recommendations
have been publicised and implemented. In
addition, it was agreed that an informal
meeting of societies and organisations committed to the implementation of the Three
Rs should be arranged at the Second World
Congress, with a view to the possible formation of an international federation.
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Conclusions and Recommendations

8.

There should also be international discussion and agreement on what levels of
animal suffering should not be permitted in any circumstances, regardless of
any likely or potential benefits.

9.

It is the responsibility of the investigator

General
1.

Existing laboratory animal protection
laws should be fully implemented.

2.

All countries should have a legal framework which actively incorporates the
Three Rs into all animal-based research,
testing and education.

3.

There should be formal and informal
mechanisms for the education and training of academic, industrial and government scientists and officials in the Three
Rs, to ensure compliance with the spirit
and letter of laboratory animal protection legislation and regulations.

4.

5.

Before proposing any programme of
work involving laboratory animals, scientists should ask themselves whether
the project is worth doing in the first
place, and, if so, whether the problem
could be approached in a different way,
for example by using in vitro methods or
animals of lower sentience.
Any proposed experiments on animals
should be subjected to prior and effective
expert review, both for scientific merit
and animal welfare considerations. All
scientists and institutions concerned
should take steps to ensure that proposed
programmes of work involving animals
which do not have to pass through an
external peer-review process are nevertheless subjected to effective evaluation
for scientific merit and necessity.

6.

Institutions should be required to
appoint one or more persons responsible
for ensuring that the Three Rs are fully
taken into consideration when programmes of work on animals are proposed and during the experimental work
itself.

7.

It should be recognised that the assessment and weighing of the likely benefit
and likely animal suffering involved in a
proposed programme of work is an
essential part of the process whereby
permission for the work to proceed is/is
not granted. Further studies should be
undertaken on how this assessment and
weighing could be conducted, as a basis
for international agreement and harmonisation.

to choose and justify, on scientific and
animal welfare grounds, the animal
species and strain which is most suitable
for the proposed investigation.
10. It is unacceptable to export scientific
work involving laboratory animals to
avoid scientifically realistic, but more
stringent, animal welfare codes.
11. Discussions should be encouraged at the

national and international level with a
view to setting targets and time limits
for the achievement of specific goals in
the reduction, refinement and replacement of the use of vertebrate animals in
experiments and other scientific procedures.
12. There is a need for the involvement in
animal welfare issues of more people
with initial training in the life sciences
and
postgraduate
training
in
biometry/statistics.

Reduction altenwtives
13. In cases where a choice between species
is possible, tHere is generally no scientific justification for using more of the
smaller species than of the larger one.
14. Research strategy should be considered
carefully, with a view to reducing the
numbers of animals used. The example
of Hendriksen ef al. (32), in choosing
strains of laboratory mice in order to
minimise the numbers needed in specific
biological assays, should be followed for
those assays which use large numbers of
animals and which are unlikely to be
replaced with in vitro alternatives in the
near future.
15. The design of regulatory testing procedures, including the sample sizes
required, should be reviewed regularly,
possibly as part of international harmonisation.
16. Substantial reduction in animal use
could be achieved by further harmonising toxicity testing regulations, for
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example, with respect to group sizes,
dose levels and the length of studies.
17. In view of the uncertainties inherent in
"extrapolating" to humans, the need for
very high precision in data provided by
animal experiments should be reconsid·
ered.

18. There is evidence that some non· regulatory animal experiments are poorly
designed an~ incorrectly analysed. As a
minimum, all research workers should
have adequate training in experimental
design and the proper use of statistical
methods.

quality of research data.
26. Journal editors should be encouraged to
include a separate consideration of
Animals and Procedures within the
Materials and Methods section of the
articles they publish.

Replacement alternatives
27. Statistics on animal use should include
the numbers of animals killed specifically for the purpose of providing cells
and tissues for in vitro studies.

19. The concept of the "named statistician"
as an essential part of the regulatory
framework of animal experimentation
should be explored.

28. In the case of regulatory efficacy and
toxicity testing, research specifically
aimed at providing validated replacement alternatives for the currently
accepted animal procedures should be
conducted.

Refinement alternatives

29. The development and acceptance of

20. An international data bank on refinement alternatives should be developed.

21. The validation process should include
the evaluation of refinement alternative
procedures, particularly in relation to
regulatory testing.
22. There should be internationally agreed
guidelines for the categorisation of animal pain, distress and other adverse
effects, including agreement on physiological and behavioural signs for the
recognition of adverse effects and for
their measurement.
23. Working parties should be set up, on an
international, collaborative basis, to
develop codes of practice and guidelines
of best practice for specific animal husbandry (welfare) and research proce·
dures. When such codes and guidelines
have been developed and agreed, adherence to them should be mandatory.
24. Individuals and institutions should be
responsible to their national authorities
for prospective and retrospective assessments of the nature and levels of adverse
effects likely to be experienced or actu·
ally experienced by animals in each programme of work.
25. Research on refinement and welfare
aspects should be encouraged and
funded, including studies on the effects
of minimising pain and distress on the

replacement alternatives for both
research and testing must be based on
an understanding of the molecular and
cellular mechanistic basis of the phe.
nomenon being studied or measured.
The current trend toward a more mechanistic approach should be welcomed,
encouraged and financially supported.
30. Monoclonal antibodies should only be
produced by using in vitro methods,
unless a convincing scientific case can be
made for using the mouse ascites technique.
31. New in vitro methods for the production
of hormones and other biological prod~
ucts, which would result in purer preparations, should be sought. Efforts
should be made to determine whether in
vivo bioassays for the safety and efficacy
testing of hormones and related products can be replaced by using a combina~
tion of physicochemical and in vitro
tests.
32. The animal welfare and ethical issues
pertaining to the procurement of fetal
and neonatal calf sera should be investigated. The development of fullJ defined
substitutes which could replace the use
of serum when culturing cells should be
encouraged.
33. Since it is unlikely that an animal test
could be replaced with a single in vitro
test, the development, evaluation and
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optimisation of testing strategies and
integrated testing schemes should be a
high priority.
34. Human cells and tissues should be used
in preference to those isolated from laboratory animals whenever possible.
However, it is recognised that there are
ethical, safety, legal and logistical problems which may prevent the widespread
use of human tissues.
Educahon and training
35. A clear distinction needs to be made
between education which aims to contribute to the development of proper
attitudes toward the use of animals, and
the training of individuals who will be
practicalIy involved in animal experimentation itselC be it by conducting
experiments, by contracting or permitting experiments, or by caring for the
animals used.
36. The responsible authorities should
require that all those with any practical
involvement should take accredited
courses which em phasise the importance
of all of the Three Rs, and the legal
requirement to use alternatives whenever possible. Emphasis should be placed
on "best practice", for the sake of both
8cientific quality and the welfare of the
animals used.

37. Permission to conduct experimental procedures on animals should be based not
only on general training, but also on specific training and evidence of competence, which should be reassessed
regularly.
38. A Three Rs education and training database should be established, so that all
concerned can have easy access to information and advice on the availability of
relevant literature.

39. School students and undergraduates
should not be forced to conduct procedures on animals as part of their
courses, but, should, where necessary, be
provided with alternative options.
Informing scientists about the Three Rs
concept
40. National, regional and international centres should be established to facilitate

and promote research and the implementation of the Three Rs through funding and education. These centres should
be networked, to facilitate coordination
and information exchange.
41. Government, industrial and academic
scientists should be encouraged to
become involved to a greater extent in
the development, validation and implementation of alternative methods.
42. Funding agencies should allocate funds
specifically for research on all of the
Three Rs.
43. The concept and availability of the Three
Rs, in the context of excellence and
humanity in scientific research, should
be incorporated into graduate education
and into training programmes which
also cover experimental design, animal
welfare issues and statistics.
44. The editors of appropriate academic
journals should be encouraged to introduce regular and specific consideration
of progress in the Three Rs in relation to
the subject areas covered by their journals.
45. The officers of learned societies should
be encouraged to establish subdisciplines within their organisations to consider the Three Rs aspects of their
disciplines, thereby encouraging recognition of the scientific and humanitarian
importance of the Three Rs concept.

Informing the general public about the
Three Rs
46. Organisations concerned in promoting
all types of alternative methods should
devote some of their energies to informing the general public of the nature and
importance of the Three Rs approach.
47. Such organisations should consider joint
efforts, as a means of improving quality,
avoiding pitfalls, and sharing costs.
When appropriate, concerted advertising, mailings and other actions should be
devised and implemented, to take advantage of timely, high profile issues,
whether to encourage positive developments or to forestall negative develop·
ments.
48. Priority should be given to providing
materials for teachers.
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49. Organisers of workshops, conferences
and other meetings on the Three Rs,
should, when appropriate, consider publicising the outcome of such meetings.
Lay summaries of the proceedings of
meetings on alternatives should, when
appropriate and feasible, be published.

Special considerations
50. Animal welfare considerations should be
an essential part of the evaluation of the
acceptability of proposed new regulatory
test guidelines, or modifications of existing guidelines.
51. When a new regulatory test guideline
has been accepted, which involves fewer
animals or less animal suffering, it
should not be optional, but should be
required in preference to any other
method.
52. Wherever possible, quantitative endpoints should be used. Death and other
qualitative endpoints are often inhumane, and provide less information than
quantitative measurements. It is inexcusable to use lethal endpoint acute toxicity tests (for example, LD50 tests),
when a non-lethal endpoint test (for
example, the Fixed Dose Procedure) has
been formally accepted as an alternative
OEeD test guideline method.
53. When challenge of experimental animals
is unavoidable as, for example, in vaccine
potency testing, clear clinical symptoms
should be taken as being equivalent to
the lethality endpoint, and animals
showing such symptoms should then be
killed humanely.
54. A proposed alternative approach for estimating vaccine potency should be evaluated, which involves limiting the use of
animals to the first few batches, while
monitoring the consistency of the quality 'of subsequent batches by using in
vitro methods.
55. Since it is of questionable value, the use
of the Abnormal Toxicity Test in vaccine
safety testing should be discontinued.
56. Urgent consideration should be given to
the revision of laws and regulations concerning the use of animals, so that,
where necessary, animals with a deleterious phenotype, whether spontaneous

or caused by mutagens or transgenic
techniques, are afforded the same level
of protection throughout their lives as
that which would be appropriate had
that level of suffering been induced by
any other method or technique.
57. There should be a review of the systems
currently used for evaluating the ethical
acceptability of gene transfer into animals on a case-by-case hasis, with particular emphasis on the transfer of human
genes into animals.
58. The higher primates, cats, dogs and
horses should continue to be regarded as
animals deserving special consideration.
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